Key result
The caffeine-halothane contracture test achieved a sensitivity of 97% (95% CI, 84-100%) and a specificity of 78% (95% CI, 69-85%) for diagnosing malignant hyperthermia susceptibility.
Why the study?
What is the sensitivity and specificity of the caffeine-halothane contracture test for diagnosing malignant hyperthermia susceptibility?
Case-Control (n=152)
Yes
What is the sensitivity and specificity of the caffeine-halothane contracture test for diagnosing malignant hyperthermia susceptibility?
Absolute Event Rate: 97% vs 78%
The caffeine-halothane contracture test demonstrates high sensitivity and acceptable specificity for diagnosing malignant hyperthermia susceptibility, though it is not suitable for general population screening.
No takes yet. Share an insight, caveat, or question.
CHCT supports diagnostic use in suspected MH; leaves open prospective validation of thresholds in broader populations.
Allen et al. (1998) conducted a case-control in Malignant hyperthermia (n=152). Caffeine-halothane contracture test (CHCT) vs. Low-risk controls was evaluated on Sensitivity and specificity of the CHCT (95% CI 84-100). The caffeine-halothane contracture test achieved a sensitivity of 97% (95% CI, 84-100%) and a specificity of 78% (95% CI, 69-85%) for diagnosing malignant hyperthermia susceptibility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: